The Department of Cardiothoracic Surgery at Stanford University Medical Center takes pride in the rich tradition of excellence and pioneering firsts that have made it one of the top cardiac and thoracic programs in the nation. Our long and distinguished legacy of research dates back to the late 1950s — our most notable triumphs being the first adult human heart transplant in the United States, the world's first successful adult human combined heart-lung transplant, the first successful use of a ventricular device as a bridge to transplantation, the first thoracic aortic stent graft, and the development of the first integrated platform for minimally invasive heart surgery.
Our Department is comprised of three divisions:
Together, the Department of Cardiothoracic Surgery continues to improve patient health
through continual scientific innovation, revolutionary operative care, and exemplary surgical education.
Department research and clinical expertise showcased at the American Heart Association Scientific Sessions 2019
At this year’s conference held in Philadelphia, PA, the Stanford Department of Cardiothoracic Surgery was prominently featured in 20 talks and poster presentations, showcasing a diverse spectrum of the department’s clinical expertise and research accomplishments.
Mark Berry, MD, professor of cardiothoracic surgery, was appointed the Mylavarapu Rogers Professor in Cardiothoracic Surgery. The professorship was established with a gift from Swati Mylavarapu and Matt Rogers to support a faculty member in the Department of Cardiothoracic Surgery.